5AM PARTNERS VII, LLC sold 85.8% of their position (33.89K shares) of SKYE BIOSCIENCE, INC. on the open market
Open‑market sale worth $64.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/18/2026ACC: 0001231919-26-001197
10% Owner
Since Aug 2023
-33.89K
Net shares
Net seller
$64.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
33.89K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−32.61K
Price / share
$1.91
Trade value
$62.28K
% of position
18.6%
9/16/2026
175.07K→142.46K
Common Stock
Indirect
Shares
−1.28K
Price / share
$1.91
Trade value
$2.45K
% of position
18.6%
9/16/2026
6.90K→5.62K
Total
Net shares
−33.89K
Net value
-$64.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/16/2026 | S · Sale | −32.61K | $1.91 | $62.28K | 18.6% | 175.07K | 142.46K |
| Common Stock Indirect | 9/16/2026 | S · Sale | −1.28K | $1.91 | $2.45K | 18.6% | 6.90K | 5.62K |
| Total | −33.89K | -$64.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned981.27K
Total
981.27K indirect981.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 981.27K | Indirect |
| Total | 981.27K | 981.27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported